Curated News
By: NewsRamp Editorial Staff
April 10, 2025
Can B Corp. Retains Law Firm to Monetize Cannabis Patents Valued at $750 Million
TLDR
- Can B Corp. retained Fox Rothschild to monetize $750 million worth of cannabis patents, giving them a significant advantage.
- Through Nascent Pharma Holdings, Can B Corp. owns patents covering cannabis extracts and methods of preparation, maximizing their value.
- Can B Corp.'s patents aim to provide relief for debilitating conditions like cancer, chronic pain, and anxiety, making the world a better place.
- The patents survived an invalidity challenge in Federal Court, showcasing their innovative approach to pharmaceutical solutions.
Impact - Why it Matters
This news matters as it highlights the potential value of cannabis patents and the significance of intellectual property in the pharmaceutical industry. It showcases the ongoing advancements in cannabis-based treatments for a range of debilitating conditions, which could have a significant impact on the medical field.
Summary
Can B Corp. announces it has retained Fox Rothschild, a law firm, to monetize its cannabis patents valued at up to $750 million. The patents cover liquid formulations of cannabis and methods of use for managing various conditions.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, Can B Corp. Retains Law Firm to Monetize Cannabis Patents Valued at $750 Million
